# Efficacy and Safety of Dihydroartemisinin-piperaquine (DHP) for the Treatment of Uncomplicated Malaria

> **NCT02353494** · — · COMPLETED · sponsor: **Menzies School of Health Research** · enrollment: 130 (actual)

## Conditions studied

- Plasmodium Falciparum Infection
- Plasmodium Vivax Infection

## Interventions

- **DRUG:** Dihydroartemisinin-Piperaquine

## Key facts

- **NCT ID:** NCT02353494
- **Lead sponsor:** Menzies School of Health Research
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2017-02-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02353494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02353494, "Efficacy and Safety of Dihydroartemisinin-piperaquine (DHP) for the Treatment of Uncomplicated Malaria". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02353494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*